Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Univar's (UNVR) Earnings And Revenues Top Estimates In Q1

Published 05/10/2018, 09:36 PM
Updated 07/09/2023, 06:31 AM

Univar Inc. (NYSE:UNVR) logged a profit (on a reported basis) of $65.4 million or 46 cents per share in first-quarter 2018, rising almost three-fold from $22.6 million or 16 cents a year ago.

Barring one-time items, earnings came in at 42 cents per share in the quarter, surpassing the Zacks Consensus Estimate of 38 cents.

The chemical maker’s revenues rose 8% year over year to $2,158 million in the quarter, beating the Zacks Consensus Estimate of $2,137 million.

Gross profit rose around 10.7% year over year to $486.6 million in the quarter with gains witnessed across all segments. Adjusted EBITDA margin increased 70 basis points to 7.7%.



Univar Inc. Price, Consensus and EPS Surprise

Segment Review

Revenues from the USA division increased 4.6% year over year to $1.2 billion in the reported quarter. Gross profit rose 6.1% year over year to $278.9 million.

Revenues from the Canada segment went up around 2% to $313.4 million. Gross profit rose roughly 11.8% to $62.4 million in the quarter.

The EMEA segment raked in sales of $538.6 million, up 22.5%. Gross profit rose around 21.8% to $124 million.

Sales from the Rest of World unit inched up 0.7% to $101.6 million. Gross profit grew 12.7% year over year to $21.3 million.

Balance Sheet

Univar ended the quarter with cash and cash equivalents of $115.9 million, down around 61.4% year over year. Long-term debt was $2,683.5 million, down around 7.6% year over year.

Outlook

For full-year 2018, Univar sees adjusted EBITDA growth of low-double digits. For 2018, adjusted earnings are expected in the range of $1.65-$1.85 per share, up from the previous guidance of $1.60-$1.80.

The company expects strong core business performance in the second quarter of 2018. It expects high single digit growth in adjusted EBITDA for the second quarter.

Price Performance

Univar has underperformed the industry over the last six months. The company’s shares have lost 11.8% over this period compared with the industry’s 3.1% decline.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Zacks Rank & Other Stocks to Consider

Univar carries a Zacks Rank #2 (Buy).

Some other top-ranked companies in the basic materials space worth considering are FMC Corporation (NYSE:FMC) , Huntsman Corporation (NYSE:HUN) and Celanese Corporation (NYSE:CE) . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 20.2% over a year.

Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 22.5% over a year.

Celanese has an expected long-term earnings growth rate of 8.9%. Its shares have gained around 28.5% over a year.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Celanese Corporation (CE): Free Stock Analysis Report

FMC Corporation (FMC): Free Stock Analysis Report

Huntsman Corporation (HUN): Free Stock Analysis Report

Univar Inc. (UNVR): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.